NovAccess Global Advisory on Annual Meeting of Shareholders
NovAccess Global Advisory on Annual Meeting of Shareholders
CLEVELAND, OH / ACCESSWIRE / May 7, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the postponement of its Annual Meeting of Shareholder which was previously scheduled to be held in May 2024. The Company expects to reschedule the annual meeting shortly.
2024年5月7日訊 / ACCESSWIRE / 諾沃訊全球公司(OTCQB：XSNX)宣佈推遲原定於2024年5月舉行的股東大會，該公司正在制定新的股東大會計劃。該公司是一家生物醫藥公司，爲腦瘤患者開發新型免疫療法。
The Company previously announced that it would be hosting a virtual annual meeting of shareholders on May 6th, 2024 for shareholders of record as of April 1, 2024.
該公司曾宣佈將於2024年5月6日爲截至2024年4月1日持有該公司股份的股東舉行虛擬股東大會。th該公司曾宣佈將於2024年5月6日爲截至2024年4月1日持有該公司股份的股東舉行虛擬股東大會。
About NovAccess Global
關於NovAccess Global
NovAccess Global is a biomedical company accelerating novel cancer diagnostics and therapeutics. Our goal is to discover, develop and bring to market novel and innovative medicine and medical devices to improve the quality of care for cancer and neurological patients.
NovAccess Global是一家生物醫藥公司，加速創新癌症診斷和治療方法的發展。我們的目標是發現，開發和推向市場新型和創新的藥品和醫療設備，以改善癌症和神經系統疾病患者的護理質量。
Follow us on social media and stay up to date on all of our developments:
關注我們的社交媒體以獲取我們所有發展動態：
Forward-Looking Statement
前瞻性聲明
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in the Company's disclosures or filings with the Securities Exchange Commission. You are further cautioned that penny stocks and stocks of smaller companies like NovAccess Global Inc. are inherently volatile and risky and that no investor should buy this stock unless they can afford the loss of their entire investment. The Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date thereof.
本新聞稿包含“前瞻性聲明”，根據《1933年證券法》第27A條(經修正)和《1934年證券交易法》第21E條(經修正)制定，此類前瞻性聲明是根據1995年《私人證券訴訟改革法案》安全港規定製定的。 “前瞻性聲明”描述未來期望、計劃、結果或策略，通常以“可能”、“未來”、“計劃”或“已計劃”、“將”或“應該”、“預期”、“預計”、“草案”、“最終”或“預計”等字開頭。您被警告，此類陳述受到許多風險和不確定性的影響，這些風險和不確定性可能導致未來情況、事件或結果與前瞻性聲明中預測的情況、事件或結果有所不同，包括一些因素可能導致實際結果與前瞻性聲明中預測的結果有很大區別，在公司的披露或提交給證券交易委員會的文件中發現的其他風險。您還受到警告，低價股票和像諾沃訊全球公司這樣的小公司的股票具有本質上的波動性和風險，在沒有能力承受整個投資損失的情況下，任何投資者都不應該購買此股票。該公司不承擔更新任何前瞻性聲明以反映之後事件或情況的責任。
Investor Relations Contact:
投資者關係聯繫人：
Jordan Darrow
Darrow Associates
631-766-4528
jdarrow@darrowir.com
Jordan Darrow
Darrow Associates
631-766-4528
jdarrow@darrowir.com
SOURCE: NovAccess Global Inc.
來源：NovAccess Global Inc。